Copper Gluconate: Clinical Trials

9 trials of Copper Gluconate, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

3 completed, 3 terminated, 2 recruiting, 1 unknown. 6 Phase 1, 2 Phase 2, 1 Early Phase 1, 1 Not applicable.

By phase and status

PhaseTrialsStatus
Phase 16Completed 2, Terminated 2, Recruiting 1, Unknown 1
Phase 22Completed 1, Terminated 1
Early Phase 11Completed 1
Not applicable1Recruiting 1

Follow Copper Gluconate: new trials by email Literature Review of Copper Gluconate trials Research Report on Copper Gluconate

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Copper Supplementation in Cirrhosis
Copper Gluconate - Cirrhosis, Chronic Liver Disease
Not applicableRecruitingUniversity of Washington302026-03-152026-03-13
Disulfiram With Copper Gluconate and Liposomal Doxorubicin in Treatment-Refractory Sarcomas
Disulfiram, Copper Gluconate, Liposomal Doxorubicin (Doxil) - Relapsed Sarcomas
Phase 1RecruitingCase Comprehensive Cancer Center242023-03-092026-08-06
Study of Disulfiram and Copper Gluconate in Patients With Treatment-Refractory Multiple Myeloma
Disulfiram, Copper Gluconate - Multiple Myeloma
Phase 1TerminatedUniversity of Utah22021-05-212023-03-13
Disulfiram and Copper Gluconate With Temozolomide in Unmethylated Glioblastoma Multiforme
Disulfiram, Copper gluconate, Temozolomide - Glioblastoma, Glioblastoma Multiforme
Phase 2TerminatedWake Forest University Health Sciences152018-03-282024-10-03
A Phase Ib Study of Intravenous Copper Loading With Oral Disulfiram in Metastatic, Castration Resistant Prostate Cancer
Copper, Disulfiram, Copper gluconate - Prostate Cancer
Phase 1TerminatedDaniel George, MD92017-07-112021-09-16
Disulfiram/Copper With Concurrent Radiation Therapy and Temozolomide in Patients With Newly Diagnosed Glioblastoma
Disulfiram, Copper Gluconate, Surgery - Glioblastoma Multiforme
Phase 1 / Phase 2CompletedWashington University School of Medicine352016-06-152025-04-10
Disulfiram in Treating Patients With Glioblastoma Multiforme After Radiation Therapy With Temozolomide
Temozolomide, Disulfiram, Copper gluconate - Glioblastoma
Early Phase 1CompletedWashington University School of Medicine212013-10-102018-07-20
Human Biomarkers for Assessing Copper Deficiency
Copper gluconate - Copper Deficiency
Phase 1UnknownPurdue University702010-11-012017-04-19
Phase I Study of Disulfiram and Copper Gluconate for the Treatment of Refractory Solid Tumors Involving the Liver
Disulfiram, Copper Gluconate - Cancer
Phase 1CompletedUniversity of Utah212008-07-012014-10-31

Conditions studied

Glioblastoma (3)  ·  Fibrosis (1)  ·  Infections (1)  ·  Malnutrition (1)  ·  Multiple Myeloma (1)  ·  Neoplasms (1)  ·  Osteosarcoma (1)  ·  Prostatic Neoplasms (1)  ·  Rhabdomyosarcoma (1)  ·  Sarcoma (1)  ·  Sarcoma, Ewing (1)

Sponsors

University of Utah (2)  ·  Washington University School of Medicine (2)  ·  Case Comprehensive Cancer Center (1)  ·  Daniel George, MD (1)  ·  Purdue University (1)  ·  University of Washington (1)  ·  Wake Forest University Health Sciences (1)

Countries

United States (9)

Top investigators

Jiayi Huang, M.D. (2)  ·  Asadullah Khan, MD (1)  ·  Daniel George, MD (1)  ·  Douglas Sborov, MD (1)  ·  Kenneth Grossmann, MD, PhD (1)  ·  Lei Yu, MD (1)  ·  Matteo Trucco, MD (1)

Results publications

PMID 24344045, PMID 33957901, PMID 35285015, PMID 38768767

NIH funding

R01DK142802 (1)